Sign in Subscribe
Cancer research

Smart Drug Delivery Systems for Cancer Therapy: A Breakthrough in Cancer Gene Therapy

Strategic Insights

— 1 min read

Research conducted at the "Grigore T. Popa" University of Medicine and Pharmacy in Iasi, Romania, has made significant advancements in cancer gene therapy. Despite the limitations of conventional therapy, including low water solubility, bioavailability, and high dose-dependent toxicity, scientists have developed new delivery methods for antineoplastic drugs. By complexing antitumor drugs with cyclodextrins (CDs) and chitosan (CS), researchers aim to counteract these primary limitations and enhance the release of bioactive compounds at tumor sites.

Key Takeaways:

  • Researchers have developed smart drug delivery systems based on cyclodextrins and chitosan to improve cancer therapy outcomes.
  • Conventional therapy limitations, such as low water solubility and bioavailability, have been addressed through the complexation of antitumor drugs with CDs and CS.
  • The complexation of antitumor drugs with CDs and CS has shown potential in overcoming drug resistance and reducing systemic toxicity.
  • Recent research on nanostructures and functional materials employed in oncological therapies has focused on enhancing the release of bioactive compounds at tumor sites.
  • The most notable research in this field has been published in several scientific articles between 2019 and 2025, with many studies investigating the use of various stimuli, such as pH, redox potential, and folate receptor levels, to facilitate drug release.
  • In this review, researchers exclusively addressed the use of pH, redox potential, and folate receptor levels as stimuli for drug release.

Statistics:

  • Between 2019 and 2025, there has been a significant increase in research on nanostructures and functional materials employed in oncological therapies.
  • According to the review, the majority of the cited references focus on the most notable research, studies of novel applications, and scientific advancements in the development of nanostructures and functional materials.
  • The researcher's analysis suggests that there are additional stimuli with research potential that can facilitate the drug's release upon activation, such as reactive oxygen species (ROS), various enzymes, ATP level, or hypoxia.

Sources:

  • "Smart Drug Delivery Systems Based on Cyclodextrins and Chitosan for Cancer Therapy." Pharmaceuticals, 2025, 18(4), 564. (Pharmaceuticals - http://www.mdpi.com/journal/pharmaceuticals/).
  • "NewsRx. Researchers from 'Grigore T. Popa' University of Medicine and Pharmacy Detail Research in Cancer Gene Therapy (Smart Drug Delivery Systems Based on Cyclodextrins and Chitosan for Cancer Therapy)." Cancer Weekly. May 13, 2025; p 43.

Read more